Recent evaluation of antimicrobial resistance in β-hemolytic streptococci

Clinical Infectious Diseases

Volumn 24, Issue 1 SUPPL., 1997, Pages

  Kaplan, Edward L ^a,b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CEFACLOR; CEFALOTIN; CEFIXIME; CEFPODOXIME; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; MACROLIDE; PENICILLIN DERIVATIVE; PENICILLIN G; SULFANILAMIDE DERIVATIVE; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BETA HEMOLYTIC STREPTOCOCCUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS GROUP A;

DRUG RESISTANCE, MICROBIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS;

EID: 0031030131     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/24.supplement_1.s89     Document Type: Article

References (15)

1. Kaplan EL. Global assessment of rheumatic fever and rheumatic heart disease at the close of the century. The influences and the dynamics of population and pathogens: a failure to realize prevention? Circulation 1993;88:1964-72.
2. Stevens DL, Gibbons AE, Bergstrom R, Winn V. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis 1988;158:23-8.
3. Kaplan EL. Benzathine penicillin G for treatment of group A streptococcal pharyngitis: a reappraisal in 1985. Pediatr Infect Dis 1985;4:592-6.
4. Smith TD, Huskins WC, Kim KS, et al. Efficacy of a beta-lactamase resistant penicillin and influence of penicillin tolerance in eradicating streptococci from the pharynx after failure of penicillin therapy for group A streptococcal pharyngitis. J Pediatr 1987;110:777-82.
5. Still JG, Hubbard WC, Poole JM, Sheaffer CI, Chartrand S, Jacobs R. Comparison of clarithromycin and penicillin VK suspensions in the treatment of children with streptococcal pharyngitis and review of currently available alternative antibiotic therapies. Pediatr Infect Dis J 1993;12(suppl no 3):S134-41.
6. Gutmann L, Tomasz A. Penicillin-resistant and penicillin-tolerant mutants of group A streptococci. Antimicrob Agents Chemother 1982;22:128-36.
7. Gerber MA. Antibiotic resistance in group A streptococci. Pediatr Clin North Am 1995;42:539-51.
8. Kim KS, Kaplan EL. Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis. J Pediatr 1985;107:681-4.
9. Kaplan EL, Gastanaduy AS, Huwe BB. The role of the carrier in treatment failures after antibiotic for group A streptococci in the upper respiratory tract. J Lab Clin Med 1981;98:326-35.
10. Coonan KM, Kaplan EL. In vitro susceptibility of recent North American group A streptococcal isolates to eleven oral antibiotics. Pediatr Infect Dis J 1994;13:630-5.
11. Nakae M, Murai T, Kaneko Y, Mitsuhashi S. Drug resistance in Streptococcus pyogenes isolated in Japan. Antimicrob Agents Chemother 1977;12:427-8.
12. Seppala H, Nissinen A, Jarvinen H, et al. Resistance to erythromycin in group A streptococci. N Engl J Med 1992;326:292-7.
13. Weisblum B. Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrob Agents Chemother 1995;39:797-805.
14. Berkowitz K, Regan JA, Greenberg E. Antibiotic resistance patterns of group B streptococci in pregnant women. J Clin Microbiol 1990;28:5-7.
15. Betriu C, Gomez M, Sanchez A, et al. Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci. Antimicrob Agents Chemother 1994;38:2183-6.